AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2661789 — intervention group
Group type: COMPARATOR
Intervention: Chlorpromazine
Number of subjects: 26
Study 31292845 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongxiening Granules (TXNG) 5 g per time combined with pinaverium bromide Tablet simulator (50 mg per time), 3 times per day for 6 weeks
Number of subjects: 342
Study 31292845 — intervention group
Group type: COMPARATOR
Intervention: TXNG simulator (5 g per time) combined with pinaverium bromide Tablets (50 mg per time), 3 times per day for 6 weeks
Number of subjects: 342
Study 31292845 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 342
Study 28898105 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee flexion moment (KFM) before ACLR
Number of subjects: 33
Study 28898105 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee flexion angle (KFA) before ACLR
Number of subjects: 33
Study 28898105 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee flexion moment (KFM) at 6 months after ACLR
Number of subjects: 33
Study 28898105 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee flexion angle (KFA) at 6 months after ACLR
Number of subjects: 33
Study 28898105 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical ground-reaction force (vGRF) at 6 months after ACLR
Number of subjects: 33
Study 25070686 — intervention group
Group type: EXPERIMENTAL
Intervention: (177)Lu-EDTMP at a dose of 1,295 MBq (group A)
Number of subjects: 44
Study 25070686 — intervention group
Group type: EXPERIMENTAL
Intervention: (177)Lu-EDTMP at a dose of 2,590 MBq (group B)
Number of subjects: 44
Study 25070686 — intervention group
Group type: EXPERIMENTAL
Intervention: (177)Lu-EDTMP
Number of subjects: 44
Study 23534022 — intervention group
Group type: EXPERIMENTAL
Intervention: Adper Single Bond 2 (SB)
Number of subjects: 36
Study 23534022 — intervention group
Group type: EXPERIMENTAL
Intervention: Adper Easy One (EASY)
Number of subjects: 36
Study 23534022 — intervention group
Group type: EXPERIMENTAL
Intervention: Adper SE Plus (SE)
Number of subjects: 36
Study 21735721 — intervention group
Group type: COMPARATOR
Intervention: Dohsa + Attention (D + A) group
Number of subjects: 0
Study 21735721 — intervention group
Group type: COMPARATOR
Intervention: Dohsa (D) group
Number of subjects: 0
Study 21735721 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 19529886 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter ablation for atrial fibrillation
Number of subjects: 40
Study 19529886 — intervention group
Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 40
Study 19529886 — intervention group
Group type: EXPERIMENTAL
Intervention: Average strain
Number of subjects: 40
Study 16924691 — intervention group
Group type: EXPERIMENTAL
Intervention: Farr method
Number of subjects: 550
Study 16924691 — intervention group
Group type: COMPARATOR
Intervention: ELISA method
Number of subjects: 550
Study 15453912 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 58
Study 15453912 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 11349175 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous trial of labor
Number of subjects: 505
Study 11349175 — intervention group
Group type: EXPERIMENTAL
Intervention: Induced trial of labor
Number of subjects: 505
Study 11349175 — intervention group
Group type: COMPARATOR
Intervention: Elective repeat cesarean
Number of subjects: 505
Study 8996289 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticlopidine (≥ 72 hours)
Number of subjects: 85
Study 8996289 — intervention group
Group type: COMPARATOR
Intervention: No ticlopidine or Ticlopidine (≤ 24 hours)
Number of subjects: 85
Study 8996289 — intervention group
Group type: COMPARATOR
Intervention: Ticlopidine (≤ 24 hours)
Number of subjects: 85
Study 7984592 — intervention group
Group type: EXPERIMENTAL
Intervention: Detoxication therapy at the start of combined treatment
Number of subjects: 191
Study 7984592 — intervention group
Group type: EXPERIMENTAL
Intervention: Detoxication therapy
Number of subjects: 191
Study 7984592 — intervention group
Group type: EXPERIMENTAL
Intervention: Minor hemosorption
Number of subjects: 191
Study 7984592 — intervention group
Group type: EXPERIMENTAL
Intervention: EI tests
Number of subjects: 191
Study 3545130 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil hydrochloride
Number of subjects: 7
Study 3545130 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 29769834 — intervention group
Group type: EXPERIMENTAL
Intervention: 10°C continuous knee cooling for one hour
Number of subjects: 20
Study 29769834 — intervention group
Group type: COMPARATOR
Intervention: 18°C continuous knee cooling for one hour
Number of subjects: 20
Study 29769834 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups during maximal voluntary contraction (MVC)
Number of subjects: 20
Study 26391583 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality assessment (QA) group with Doppler ultrasound (DU) and ultrasound dilution method (UDM)
Number of subjects: 196
Study 26391583 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality assessment (QA) group
Number of subjects: 196
Study 26391583 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 196
Study 25186820 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane for anaesthesia maintenance
Number of subjects: 200
Study 25186820 — intervention group
Group type: COMPARATOR
Intervention: Propofol-based total intravenous anaesthesia
Number of subjects: 200
Study 25186820 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 200
Study 25186820 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 200
Study 22344610 — intervention group
Group type: EXPERIMENTAL
Intervention: CarbCount
Number of subjects: 51
Study 22344610 — intervention group
Group type: EXPERIMENTAL
Intervention: CarbCountABC
Number of subjects: 51
Study 22344610 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 51
Study 20540447 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-regulating ear plugs (PREP)
Number of subjects: 21
Study 20540447 — intervention group
Group type: COMPARATOR
Intervention: No Pressure-regulating ear plugs (Control)
Number of subjects: 21
Study 17151594 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic containing milk drink
Number of subjects: 132
Study 17151594 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study 16379164 — intervention group
Group type: EXPERIMENTAL
Intervention: Participatory dental health education (DHE) programme
Number of subjects: 520
Study 16379164 — intervention group
Group type: COMPARATOR
Intervention: National teaching DHE programme
Number of subjects: 520
Study 16379164 — intervention group
Group type: EXPERIMENTAL
Intervention: Net cavitated carious increment
Number of subjects: 520
Study 16379164 — intervention group
Group type: EXPERIMENTAL
Intervention: Health centre staff support
Number of subjects: 520
Study 15384291 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lidocaine
Number of subjects: 24
Study 15384291 — intervention group
Group type: COMPARATOR
Intervention: 2% lidocaine with 1:80,000 epinephrine
Number of subjects: 24
Study 9974425 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT (2 mg estradiol valerate from day 1 to 21 and 1 mg cyproterone acetate from day 12 to 21)
Number of subjects: 232
Study 9974425 — intervention group
Group type: COMPARATOR
Intervention: Placebo (500 mg/d calcium lactate)
Number of subjects: 232
Study 9974425 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT
Number of subjects: 232
Study 9974425 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 232
Study 7572684 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg/day
Number of subjects: 447
Study 7572684 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 447
Study 2142575 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 micrograms of gestodene + 30 micrograms of ethinyl estradiol
Number of subjects: 68
Study 2142575 — intervention group
Group type: COMPARATOR
Intervention: 150 micrograms of desogestrel + 30 micrograms ethinyl estradiol
Number of subjects: 68
Study 7023233 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids
Number of subjects: 37
Study 7023233 — intervention group
Group type: COMPARATOR
Intervention: Antihuman thymocyte globulin (ATG)
Number of subjects: 37
Study 31867656 — intervention group
Group type: EXPERIMENTAL
Intervention: Red packaging
Number of subjects: 426
Study 31867656 — intervention group
Group type: EXPERIMENTAL
Intervention: Corrective messaging
Number of subjects: 426
Study 31867656 — intervention group
Group type: COMPARATOR
Intervention: Advertisement content recall
Number of subjects: 426
Study 30012387 — intervention group
Group type: EXPERIMENTAL
Intervention: Horticultural therapy program (twice/week for 12 sessions)
Number of subjects: 36
Study 30012387 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 36
Study 26538372 — intervention group
Group type: EXPERIMENTAL
Intervention: Circumferential ablation
Number of subjects: 119
Study 26538372 — intervention group
Group type: COMPARATOR
Intervention: Segmental ablation
Number of subjects: 119
Study 24402595 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesh Group (porcine small intestine submucosa mesh)
Number of subjects: 57
Study 24402595 — intervention group
Group type: COMPARATOR
Intervention: No Mesh Group (native tissue repair)
Number of subjects: 57
Study 24402595 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesh Group
Number of subjects: 57
Study 24402595 — intervention group
Group type: COMPARATOR
Intervention: No Mesh Group
Number of subjects: 57
Study 22030724 — intervention group
Group type: EXPERIMENTAL
Intervention: Single injection (group S): 30 mL of mepivacaine 1.5%
Number of subjects: 102
Study 22030724 — intervention group
Group type: EXPERIMENTAL
Intervention: Double injection (group D): 15 mL of mepivacaine 1.5% at the junction of the subclavian artery and the first rib, followed by 15 mL at the lateral aspect of the brachial plexus
Number of subjects: 102
Study 22030724 — intervention group
Group type: EXPERIMENTAL
Intervention: Single injection (group S)
Number of subjects: 102
Study 22030724 — intervention group
Group type: EXPERIMENTAL
Intervention: Double injection (group D)
Number of subjects: 102
Study 19776178 — intervention group
Group type: EXPERIMENTAL
Intervention: S-(-)equol administered as SE5-OH tablets (10 mg)
Number of subjects: 12
Study 19776178 — intervention group
Group type: EXPERIMENTAL
Intervention: S-(-)equol administered as SE5-OH tablets (30 mg)
Number of subjects: 12
Study 19776178 — intervention group
Group type: EXPERIMENTAL
Intervention: S-(-)equol (both doses)
Number of subjects: 12
Study 19776178 — intervention group
Group type: EXPERIMENTAL
Intervention: Equol-producer status
Number of subjects: 12
Study 17053928 — intervention group
Group type: EXPERIMENTAL
Intervention: APAP with C-Flex
Number of subjects: 15
Study 17053928 — intervention group
Group type: COMPARATOR
Intervention: Standard CPAP
Number of subjects: 15
Study 15343013 — intervention group
Group type: EXPERIMENTAL
Intervention: NIPSV
Number of subjects: 46
Study 15343013 — intervention group
Group type: COMPARATOR
Intervention: CPAP
Number of subjects: 46
Study 11181984 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril (ACE inhibitor)
Number of subjects: 0
Study 11181984 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9440721 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa-2a maintenance, 3 million U three times weekly for 1 year
Number of subjects: 315
Study 9440721 — intervention group
Group type: COMPARATOR
Intervention: No further treatment (control group)
Number of subjects: 315
Study 9440721 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa-2a maintenance
Number of subjects: 315
Study 7806024 — intervention group
Group type: EXPERIMENTAL
Intervention: Indian neonates
Number of subjects: 123
Study 7806024 — intervention group
Group type: EXPERIMENTAL
Intervention: Polynesian babies
Number of subjects: 123
Study 2570732 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine 20 mg b.i.d.
Number of subjects: 100
Study 2570732 — intervention group
Group type: COMPARATOR
Intervention: Aspirin 900 mg b.i.d. for 48 h
Number of subjects: 100
Study 2570732 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine 2 mg b.i.d.
Number of subjects: 100
Study 2570732 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 234130 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium fluoride dentifrice (0.1% F)
Number of subjects: 100
Study 234130 — intervention group
Group type: COMPARATOR
Intervention: Nonfluoride dentifrice
Number of subjects: 100
Study 31982328 — intervention group
Group type: EXPERIMENTAL
Intervention: PNEIMED training (30 hours)
Number of subjects: 40
Study 31982328 — intervention group
Group type: COMPARATOR
Intervention: Academic lessons (30 hours)
Number of subjects: 40
Study 31336766 — intervention group
Group type: EXPERIMENTAL
Intervention: Preservative-free latanoprost
Number of subjects: 108
Study 31336766 — intervention group
Group type: EXPERIMENTAL
Intervention: BAC-preserved latanoprost
Number of subjects: 108
Study 31336766 — intervention group
Group type: EXPERIMENTAL
Intervention: Preservative-free tafluprost
Number of subjects: 108
Study 31336766 — intervention group
Group type: EXPERIMENTAL
Intervention: BAC-preserved bimatoprost
Number of subjects: 108
Study 31336766 — intervention group
Group type: COMPARATOR
Intervention: Control group (no topical antiglaucoma medications)
Number of subjects: 108
Study 27070908 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time tissue elastography (RTE)
Number of subjects: 132
Study 26501236 — intervention group
Group type: EXPERIMENTAL
Intervention: Local corticosteroid therapy
Number of subjects: 182
Study 26501236 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic corticosteroid therapy
Number of subjects: 182
Study 26501236 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 182
Study 23507836 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate‐intensity endurance‐type exercise
Number of subjects: 60
Study 20958916 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic devascularization starting at the ileocolic artery
Number of subjects: 40
Study 20958916 — intervention group
Group type: COMPARATOR
Intervention: Open surgery (control group)
Number of subjects: 40
Study 19513890 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated care program (A group)
Number of subjects: 40
Study 19513890 — intervention group
Group type: COMPARATOR
Intervention: Conventional care program (C group)
Number of subjects: 40
Study 16416222 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg lafutidine
Number of subjects: 6
Study 16416222 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg famotidine
Number of subjects: 6
Study 16416222 — intervention group
Group type: COMPARATOR
Intervention: Water only (control)
Number of subjects: 6
Study 15603652 — intervention group
Group type: EXPERIMENTAL
Intervention: Absorbable polymer membrane (Seamguard, Gore) integrated into the gastric linear staple‐line (group A)
Number of subjects: 20
Study 15603652 — intervention group
Group type: COMPARATOR
Intervention: Conventional linear stapling system (group B)
Number of subjects: 20
Study 11407964 — intervention group
Group type: EXPERIMENTAL
Intervention: Live music of simple guitar accompaniment
Number of subjects: 8
Study 11407964 — intervention group
Group type: EXPERIMENTAL
Intervention: Live music of complex guitar accompaniment
Number of subjects: 8
Study 11407964 — intervention group
Group type: EXPERIMENTAL
Intervention: Recorded music of simple guitar accompaniment
Number of subjects: 8
Study 11407964 — intervention group
Group type: EXPERIMENTAL
Intervention: Recorded music of complex guitar accompaniment
Number of subjects: 8
Study 11407964 — intervention group
Group type: EXPERIMENTAL
Intervention: All conditions (live and recorded music with simple and complex guitar accompaniment)
Number of subjects: 8
Study 9164898 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrinsic myocardial composition
Number of subjects: 0
Study 9164898 — intervention group
Group type: COMPARATOR
Intervention: Left ventricular mass
Number of subjects: 0
Study 7780350 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-lumen central venous catheters (Group I, 25 patients)
Number of subjects: 50
Study 7780350 — intervention group
Group type: COMPARATOR
Intervention: Double-lumen central venous catheters (Group II, 25 patients)
Number of subjects: 50
Study 2171617 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral salbutamol
Number of subjects: 0
Study 2171617 — intervention group
Group type: COMPARATOR
Intervention: Untreated matched controls
Number of subjects: 0
Study 2171617 — intervention group
Group type: EXPERIMENTAL
Intervention: Ex vivo incubation with digoxin
Number of subjects: 0
Study 377038 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim/sulphamethoxazole (TMP/SMX)
Number of subjects: 56
Study 377038 — intervention group
Group type: COMPARATOR
Intervention: Doxycycline
Number of subjects: 56
Study 31038418 — intervention group
Group type: EXPERIMENTAL
Intervention: Recreational music therapy (RMT)
Number of subjects: 113
Study 31038418 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational lyric analysis for illness management and recovery (ELA-IMR)
Number of subjects: 113
Study 31038418 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational songwriting for illness management and recovery (ESW-IMR)
Number of subjects: 113
Study 31891605 — intervention group
Group type: EXPERIMENTAL
Intervention: D2/D3 receptor agonist pramipexole
Number of subjects: 0
Study 31891605 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 27819192 — intervention group
Group type: EXPERIMENTAL
Intervention: Elbow-toe bridge
Number of subjects: 9
Study 27819192 — intervention group
Group type: EXPERIMENTAL
Intervention: Side bridge
Number of subjects: 9
Study 26655885 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-W endovenous laser ablation
Number of subjects: 36
Study 26655885 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-W endovenous laser ablation
Number of subjects: 36
Study 23721411 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of gentamicin in combination with metronidazole
Number of subjects: 500
Study 23721411 — intervention group
Group type: COMPARATOR
Intervention: Multiple doses of gentamicin in combination with metronidazole
Number of subjects: 500
Study 21435220 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproic acid (VPA) treatment
Number of subjects: 22
Study 18533896 — intervention group
Group type: EXPERIMENTAL
Intervention: GluF (glucose+fructose)
Number of subjects: 20
Study 18533896 — intervention group
Group type: COMPARATOR
Intervention: Glu (glucose alone)
Number of subjects: 20
Study 17926989 — intervention group
Group type: EXPERIMENTAL
Intervention: WF10 (0.5 mL/kg body weight/day for five consecutive days, repeated every 3 weeks)
Number of subjects: 13
Study 17926989 — intervention group
Group type: COMPARATOR
Intervention: Control (radiotherapy alone)
Number of subjects: 13
Study 15528775 — intervention group
Group type: EXPERIMENTAL
Intervention: Academic detailing plus printed materials
Number of subjects: 31
Study 15528775 — intervention group
Group type: COMPARATOR
Intervention: Printed materials only
Number of subjects: 31
Study 11863318 — intervention group
Group type: EXPERIMENTAL
Intervention: Jet nebulizer with glass ampoule (group JG)
Number of subjects: 27
Study 11863318 — intervention group
Group type: EXPERIMENTAL
Intervention: Jet nebulizer with polycarbonate ampoule (group JP)
Number of subjects: 27
Study 11863318 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic nebulizer (group US)
Number of subjects: 27
Study 11863318 — intervention group
Group type: EXPERIMENTAL
Intervention: Jet nebulizers (group JG and JP)
Number of subjects: 27
Study 8707752 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg valaciclovir
Number of subjects: 18
Study 8707752 — intervention group
Group type: COMPARATOR
Intervention: 30 mL Maalox 65 min after valaciclovir
Number of subjects: 18
Study 8707752 — intervention group
Group type: COMPARATOR
Intervention: 30 mL Maalox 30 min before valaciclovir
Number of subjects: 18
Study 1602388 — intervention group
Group type: COMPARATOR
Intervention: i.v. cocaine hydrochloride (0, 16 and 32 mg)
Number of subjects: 10
Study 1602388 — intervention group
Group type: COMPARATOR
Intervention: smoked cocaine base (0, 25 and 50 mg)
Number of subjects: 10
Study 1602388 — intervention group
Group type: COMPARATOR
Intervention: smoked cocaine base (50 mg)
Number of subjects: 10
Study 1602388 — intervention group
Group type: EXPERIMENTAL
Intervention: smoked cocaine
Number of subjects: 10
Study 1602388 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. cocaine
Number of subjects: 10
Study 6186980 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention (audio-visual presentation and handout materials)
Number of subjects: 127
Study 6186980 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 127
Study 6186980 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (experimental and control)
Number of subjects: 127
Study 31512140 — intervention group
Group type: EXPERIMENTAL
Intervention: CAGIB score
Number of subjects: 1682
Study 31512140 — intervention group
Group type: COMPARATOR
Intervention: Child-Pugh score
Number of subjects: 1682
Study 31512140 — intervention group
Group type: COMPARATOR
Intervention: MELD score
Number of subjects: 1682
Study 31512140 — intervention group
Group type: COMPARATOR
Intervention: MELD-Na score
Number of subjects: 1682
Study 31512140 — intervention group
Group type: COMPARATOR
Intervention: NLR score
Number of subjects: 1682
Study 29912422 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided de-escalation regimen (1 week prasugrel followed by 1 week clopidogrel and guided maintenance therapy)
Number of subjects: 2610
Study 29912422 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment with prasugrel for 12 months (control group)
Number of subjects: 2610
Study 26123574 — intervention group
Group type: EXPERIMENTAL
Intervention: Education intervention
Number of subjects: 245
Study 26123574 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support intervention
Number of subjects: 245
Study 26123574 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 245
Study 24119678 — intervention group
Group type: EXPERIMENTAL
Intervention: Triplex Doppler ultrasonography (TDU)
Number of subjects: 24